Login / Signup

Randomized, double-blind, placebo-controlled, crossover study of the effects of repeated-dose caffeine on neurobehavioral performance during 48 h of total sleep deprivation.

Devon A HansenSridhar RamakrishnanBrieann C SatterfieldNancy J WesenstenMatthew E LaytonJaques ReifmanHans P A Van Dongen
Published in: Psychopharmacology (2018)
The neurobehavioral effects of repeated caffeine dosing during sleep deprivation were most evident during the circadian alertness trough (i.e., at night). The difference between the 200 mg and 300 mg doses, in terms of the mitigation of performance impairment, was small. Neither caffeine dose fully restored performance to well-rested levels. These findings inform the development of biomathematical models that more accurately account for the time of day and sleep pressure-dependent effects of caffeine on neurobehavioral performance during sleep loss.
Keyphrases
  • placebo controlled
  • double blind
  • sleep quality
  • physical activity
  • phase iii
  • clinical trial
  • phase ii
  • open label
  • randomized controlled trial
  • study protocol
  • climate change
  • phase ii study
  • radiation therapy